Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND Study

BACKGROUND. Immunosuppression with calcineurin inhibitors (CNIs) is reportedly associated with risk of renal impairment in liver transplant recipients. It is believed that this can be mitigated by decreasing initial exposure to CNIs or delaying CNI introduction until 3–4 d posttransplantation. The A...

Descripción completa

Detalles Bibliográficos
Autores principales: Friman, Styrbjörn, Tisone, Giuseppe, Nevens, Frederik, Lehner, Frank, Santaniello, Walter, Bechstein, Wolf O., Zhuvarel, Sergey V., Isoniemi, Helena, Rummo, Oleg O., Klempnauer, Jürgen, Anaokar, Swapneel, Hurst, Martin, Kazeem, Gbenga, Undre, Nasrullah, Trunečka, Pavel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Liver Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274734/
https://www.ncbi.nlm.nih.gov/pubmed/34263020
http://dx.doi.org/10.1097/TXD.0000000000001166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274734/
https://www.ncbi.nlm.nih.gov/pubmed/34263020
http://dx.doi.org/10.1097/TXD.0000000000001166

Ejemplares similares